Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/110336
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Food Science and Nutrition-
dc.creatorDu, QH-
dc.creatorGao, C-
dc.creatorTsoi, B-
dc.creatorWu, ML-
dc.creatorShen, JA-
dc.date.accessioned2024-12-03T03:34:02Z-
dc.date.available2024-12-03T03:34:02Z-
dc.identifier.urihttp://hdl.handle.net/10397/110336-
dc.language.isoenen_US
dc.publisherFrontiers Research Foundationen_US
dc.rights© 2024 Du, Gao, Tsoi, Wu and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_US
dc.rightsThe following publication Du Q, Gao C, Tsoi B, Wu M and Shen J (2024) Niuhuang Qingxin Wan ameliorates depressive-like behaviors and improves hippocampal neurogenesis through modulating TrkB/ERK/CREB signaling pathway in chronic restraint stress or corticosterone challenge mice. Front. Pharmacol. 14:1274343 is available at https://dx.doi.org/10.3389/fphar.2023.1274343.en_US
dc.subjectNiuhuang Qingxin Wanen_US
dc.subjectDepressionen_US
dc.subjectHippocampal neurogenesisen_US
dc.subjectNeural stem cellsen_US
dc.subjectBDNF/TrkB/ERK/CREB pathwayen_US
dc.titleNiuhuang Qingxin Wan ameliorates depressive-like behaviors and improves hippocampal neurogenesis through modulating TrkB/ERK/CREB signaling pathway in chronic restraint stress or corticosterone challenge miceen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume14-
dc.identifier.doi10.3389/fphar.2023.1274343-
dcterms.abstractIntroduction: Chronic stress-associated hormonal imbalance impairs hippocampal neurogenesis, contributing to depressive and anxiety behaviors. Targeting neurogenesis is thus a promising antidepressant therapeutic strategy. Niuhuang Qingxin Wan (NHQXW) is an herbal formula for mental disorders in Traditional Chinese Medicine (TCM) practice, but its anti-depressant efficacies and mechanisms remain unverified.-
dcterms.abstractMethods: In the present study, we tested the hypothesis that NHQXW could ameliorate depressive-like behaviors and improve hippocampal neurogenesis by modulating the TrkB/ERK/CREB signaling pathway by utilizing two depression mouse models including a chronic restraint stress (CRS) mouse model and a chronic corticosterone (CORT) stress (CCS) induced mouse model. The depression-like mouse models were orally treated with NHQXW whereas fluoxetine was used as the positive control group. We evaluated the effects of NHQXW on depressive- and anxiety-like behaviors and determined the effects of NHQXW on inducing hippocampal neurogenesis.-
dcterms.abstractResults: NHQXW treatment significantly ameliorated depressive-like behaviors in those chronic stress mouse models. NHQXW significantly improved hippocampal neurogenesis in the CRS mice and CCS mice. The potential neurogenic mechanism of NHQXW was identified by regulating the expression levels of BDNF, TrkB, p-ERK (T202/T204), p-MEK1/2 (S217/221), and p-CREB (S133) in the hippocampus area of the CCS mice. NHQXW revealed its antidepressant and neurogenic effects that were similar to fluoxetine. Moreover, NHQXW treatment revealed long-term effects on preventing withdrawal-associated rebound symptoms in the CCS mice. Furthermore, in a bioactivity-guided quality control study, liquiritin was identified as one of the bioactive compounds of NHQXW with the bioactivities of neurogenesis-promoting effects.-
dcterms.abstractDiscussion: Taken together, NHQXW could be a promising TCM formula to attenuate depressive- and anxiety-like behaviors against chronic stress and depression. The underlying anti-depressant mechanisms could be correlated with its neurogenic activities by stimulating the TrkB/ERK/CREB signaling pathway.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationFrontiers in pharmacology, 2024, v. 14, 1274343-
dcterms.isPartOfFrontiers in pharmacology-
dcterms.issued2024-
dc.identifier.isiWOS:001148290800001-
dc.identifier.pmid38273824-
dc.identifier.eissn1663-9812-
dc.identifier.artn1274343-
dc.description.validate202412 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.fundingSourceRGCen_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextBeijing Tong Ren Tang Chinese Medicine Company Limiteden_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
fphar-14-1274343.pdf3.7 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

18
Citations as of Apr 14, 2025

Downloads

13
Citations as of Apr 14, 2025

SCOPUSTM   
Citations

7
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

4
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.